Doctors are worried that as the New Year begins, many Americans will resolve to be thinner in 2010 by using over-the-counter supplements. According to a survey conducted by ADSAM and SenseUS polling companies, about 60 percent of physicians feel troubled about the safety of taking diet pills. Not surprisingly, while physicians feel negatively about the safety of over-the-counter diet pills, they are much more comfortable about the use of injections like Botox and Restylane or even breast implants. The results were surprising, considering America's obsession with remaining fit and youthful. Additionally, the same survey showed that feelings about having breast augmentation or facial injections and using over-the-counter diet pills or Human Growth Hormone for anti-aging created fear and stress among the large majority of consumers. Although consumers were apprehensive about over-the-counter solutions, the survey results discovered that they were more comfortable with diet pills than cosmetic procedures.
Results from Cytori Therapeutics' (NASDAQ: CYTX) preclinical fat grafting study have been published in the February issue of the Annals of Plastic Surgery. This article, entitled "Supplementation of Fat Grafts with Adipose-Derived Regenerative Cells (ADRCs) Improves Long-Term Graft Retention, " examines the science behind cell-enriched autologous fat grafting and its application to cosmetic and reconstructive surgery. The results demonstrate a doubling in graft retention in cell-enriched grafts and provide insight into the mechanisms behind this improvement. The results reinforce both commercial observations and interim data from the RESTORE 2 clinical study that was presented at the San Antonio Breast Cancer Symposium in December. The preclinical results described in the paper support the potential clinical utility for cell-enriched fat grafts in cosmetic and reconstructive surgery. The key results include: - Long term retention of cell-enriched autologous fat grafts was increased two-fold over controls - Quality of the cell-enriched grafts was significantly higher than controls with an increased number of healthy fat cells and reduced formation of cysts - Improved blood vessel density in ADRC-enriched grafts - Demonstration of several critical growth factors expressed by ADRCs In this study, a mouse model of autologous fat grafting was used to compare graft retention of cell-enriched fat grafts with traditional fat grafts.
Results from Cytori Therapeutics' (NASDAQ: CYTX) preclinical fat grafting study have been published in the February issue of the Annals of Plastic Surgery. This article, entitled "Supplementation of Fat Grafts with Adipose-Derived Regenerative Cells (ADRCs) Improves Long-Term Graft Retention, " examines the science behind cell-enriched autologous fat grafting and its application to cosmetic and reconstructive surgery. The results demonstrate a doubling in graft retention in cell-enriched grafts and provide insight into the mechanisms behind this improvement. The results reinforce both commercial observations and interim data from the RESTORE 2 clinical study that was presented at the San Antonio Breast Cancer Symposium in December. The preclinical results described in the paper support the potential clinical utility for cell-enriched fat grafts in cosmetic and reconstructive surgery. The key results include: Long term retention of cell-enriched autologous fat grafts was increased two-fold over controls Quality of the cell-enriched grafts was significantly higher than controls with an increased number of healthy fat cells and reduced formation of cysts Improved blood vessel density in ADRC-enriched grafts Demonstration of several critical growth factors expressed by ADRCs In this study, a mouse model of autologous fat grafting was used to compare graft retention of cell-enriched fat grafts with traditional fat grafts.
GoodSurgeonGuide.co.uk, was launched in September 2009 and is the first website of its kind. The site is the UK's only Cosmetic Surgery review website and should be the first port of call for anyone considering cosmetic surgery, aesthetic treatments or cosmetic dentistry. The site can also play an important role for surgeons and treatment providers. The website was created by Christiana Clogg and good friend, Jennie Bassett. Both women had considered cosmetic surgery in the past and were overwhelmed by the amount of choice but the lack of guidance. The decision to undergo surgery was not an easy one, yet finding reviews and experiences from fellow cosmetic surgery patients was becoming the hardest part. It became clear that there needed to be a site that was honest, informative and completely independent from any other, a simple yet totally effective guide for all those that were considering surgery. Getting listed on GoodSurgeonGuide.co.uk is completely free and, by doing so, clinics, cosmetic surgeons, cosmetic dentists and aesthetic treatment providers can get their own profile, complete with contact details, and information about qualifications and the procedures they offer.
Detailed information on the first facial transplantation procedure performed in the United States is presented in the January issue of Plastic and Reconstructive Surgery® , the official medical journal of the American Society of Plastic Surgeons (ASPS). The journal is published by Lippincott Williams & Wilkins, a part of Wolters Kluwer Health, a leading provider of information and business intelligence for students, professionals, and institutions in medicine, nursing, allied health, and pharmacy. "We are pleased to report an excellent functional, psychological, and social outcome for our patient at 8 months following transplantation, " write Dr. Maria Z. Siemionow and colleagues of the Cleveland Clinic. Their article describes not just the transplant operation itself, but also the prolonged, arduous process of gaining approval, planning, and preparing for the groundbreaking procedure. Five-Year Effort to Prepare for Facial Transplantation Procedure The first U.S. facial transplantation procedure was performed in December, 2008, at the Cleveland Clinic.
An analysis of bariatric surgery claims, published by the Medical Defence Union, reveals that there has been a dramatic rise in the number of cases notified in the past two years. The MDU says that while the numbers of medical negligence claims arising from bariatric surgery, notified by its members working in independent practice, remains relatively low, with 35 cases notified since 2003, more than half of these were notified during 2008 and 2009. These claims involve a relatively new type of surgery, where the stomach is banded or bypassed to produce weight loss in obese patients. Not all of the cases will lead to compensation being paid to patients, as many are likely to be discontinued, but the MDU says it has identified some common themes that may help surgeons avoid problems. Dr Christine Tomkins, MDU chief executive, said: "We are starting to see the emergence of medical negligence claims being notified by our surgeon members working in independent practice who perform bariatric surgery.
Bellevue Salon Owner Sentenced To 13 Months In Prison In Connection With Unlicensed Cosmetic Treatments
XIN HE, aka FAITH HE, 46, of Issaquah, Washington, was sentenced today in U.S. District Court in Seattle to 13 months in prison and one year of supervised release for a felony count of Misbranding of a Drug While Held for Sale and two misdemeanor counts of Receipt & Proffered Delivery of Adulterated Device. HE was convicted at a bench trial October 30, 2009. She was ordered into immediate custody by U.S. District Judge Marsha J. Pechman. Today Judge Pechman observed that HE persisted in "risky and dangerous behavior, " offering unlicensed treatments despite warnings from employers, regulators, agents and others. According to testimony at trial and records filed in the case, FAITH HE used counterfeit Botox © and Restylane© on customers at her Bellevue beauty salon. FAITH HE was not a medical doctor licensed to use injectable treatments for wrinkle removal such as Botox and Restylane. According to the indictment, as early as 2004, FAITH HE injected a substance that she later represented was Restylane into the face of a Snohomish, Washington, woman.
Surgeons from UC Davis Medical Center have demonstrated that artificial muscles can restore the ability of patients with facial paralysis to blink, a development that could benefit the thousands of people each year who no longer are able to close their eyelids due to combat-related injuries, stroke, nerve injury or facial surgery. In addition, the technique, which uses a combination of electrode leads and silicon polymers, could be used to develop synthetic muscles to control other parts of the body. The new procedure is described in an article in the January-February issue of the Archives of Facial Plastic Surgery. "This is the first-wave use of artificial muscle in any biological system, " said Travis Tollefson, a facial plastic surgeon in the UC Davis Department of Otolaryngology - Head and Neck Surgery. "But there are many ideas and concepts where this technology may play a role." In their study, Tollefson and his colleagues were seeking to develop the protocol and device design for human implantation of electroactive polymer artificial muscle (EPAM) to reproducibly create a long-lasting eyelid blink that will protect the eye and improve facial appearance.
Dune Medical Completes Enrollment In MarginProbe TM Pivotal Trial For Real Time Detection Of Cancer During Breast Conservation Surgery
Dune Medical Devices announced the completion of patient enrollment in the MarginProbe™ pivotal clinical trial. The MarginProbe procedure provides surgeons with real-time detection of cancer at the edges of the tissue removed during breast conservation surgery (BCS), which is the only way to ensure the complete removal of the tumor from the breast. The randomized, controlled trial includes 664 women who underwent BCS at one of 21 leading medical facilities, with 18 in the US and three in Israel. "This trial is one of the largest randomized, controlled trials for intraoperative margin assessment ever undertaken. Completing enrollment in only 15 months is a significant accomplishment, " said lead investigator Lorraine Tafra, MD, FACS, Medical Director of Anne Arundel Breast Center, Annapolis, MD. "Because of the importance of achieving clear margins in BCS and the potential of MarginProbe to improve upon existing standards, we eagerly anticipate the trial results. Such a rigorous trial has the potential to help us in the development of better breast surgery techniques.
Excaliard Pharmaceuticals, Inc. announced the initiation of three proof of concept Phase 2 trials of EXC 001, an antisense medicine that reduces fibrosis, for the amelioration of skin scarring and other fibrotic disorders. The U.S. multicenter trials will test the efficacy, safety, and tolerability of EXC 001 in two different models to evaluate the improvement of the appearance of scars in subjects undergoing elective abdominoplasty surgery and revision of scars associated with prior breast surgery. "The prevention and treatment of unsatisfactory skin scarring remains an important unmet medical need, " said Lincoln Krochmal, MD, CEO & President of Excaliard Pharmaceuticals. "Unsatisfactory skin scarring can be associated with various dermatologic conditions such as hypertrophic scars and keloids, elective and reconstructive surgery, traumatic wounds, Caesarian sections and burns. We are delighted with our Phase 1 study results indicating EXC 001 delivered locally has a very impressive safety profile.